InvestorsHub Logo
Followers 79
Posts 24639
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Thursday, 02/29/2024 8:52:31 AM

Thursday, February 29, 2024 8:52:31 AM

Post# of 27557
NRBO - 5.12 Pre-market at 5.52/5.57

NeuroBo Pharmaceuticals Receives First Site IRB Approval For Its Phase 1 Clinical Trial Evaluating DA-1726 For Treatment Of Obesity

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.